| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |